why choose us

First received: October 23, 2023

Clinical Trial: A Phase 1a Study of PMN310 In Healthy Volunteers

Study Status: Completed

Recruit Status: RECRUITING

Condition: Healthy Participants

Study Type: INTERVENTIONAL


Official Title: A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of the Safety, Tolerability and Pharmacokinetics of PMN310 Infusions in Healthy Volunteers

Brief Summary: This first in human Phase 1a clinical trial will evaluate the safety, tolerability, and pharmacokinetics of a single IV infusion of PMN310 in healthy volunteers.

Read more